Tissue-specific cancer stem/progenitor cells: Therapeutic implications

doi:10.4252/wjsc.v15.i5.323

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3409)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

135

WORD

HTML

1669

Figures (1-2)

166

Tables (1-1)

182

Sum=2202

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

133

Download

459

Sum=592

Publishing Process of This Article

Item

Count

Browse

244

Download

371

Sum=615

May 26, 2023 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. May 26, 2023; 15(5): 323-341
Published online May 26, 2023. doi: 10.4252/wjsc.v15.i5.323

Full Size Figure Download Figure

Figure 1 Schematic presentation of cancer stem cell markers and their contribution to cancer development, progression, and resistance to therapy. Several cancer stem cell (CSC) markers and regulatory signaling pathways are involved in the sustenance and activation of self-renewal, immune evasion, and tumor metastasis, and contribution to tumor re-growth and therapy resistance. CSC markers serve as potential therapeutic targets for cancer treatment. CSCs: Cancer stem cells.

Citation: Yehya A, Youssef J, Hachem S, Ismael J, Abou-Kheir W. Tissue-specific cancer stem/progenitor cells: Therapeutic implications. World J Stem Cells 2023; 15(5): 323-341
URL: https://www.wjgnet.com/1948-0210/full/v15/i5/323.htm
DOI: https://dx.doi.org/10.4252/wjsc.v15.i5.323